Stock listing

Forte Biosciences, Inc.

Selected listing: FBRX · NASDAQ · USD · US

Forte Biosciences, Inc. (NASDAQ:FBRX), Health Technology. Latest release Jul 9, 2026: FB102 Achieves Statistically Significant Improvement in Vitiligo at Week…

FBRX:NASDAQUSDUSUpdated October 4, 2026

Ticker: NASDAQ:FBRX
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

About Forte Biosciences, Inc.

Forte Biosciences, Inc. is a public company traded under the ticker FBRX in the American market. Forte Biosciences focuses on developing innovative therapies to address unmet medical needs.

Latest news from Forte Biosciences, Inc.

FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period

July 9, 2026

Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update

May 11, 2026

Forte Biosciences Announces Pricing of $150 Million Public Offering

April 7, 2026

Forte Biosciences, Inc. Announces 2025 Results and Provides Update

March 30, 2026

Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules

March 3, 2026

All Forte Biosciences, Inc. news →

Events

Replays

Forte Biosciences, Inc. (FBRX) Q1 2021 Earnings Call
Mon, May 10, 2021 · 04:30 PM ET
Watch

Research Forte Biosciences, Inc.

Forte Biosciences, Inc. company profile

View the public company page for Forte Biosciences, Inc. on 6ix.

Forte Biosciences, Inc. news

Read company news and market updates connected to Forte Biosciences, Inc..

Forte Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Forte Biosciences, Inc..